Long‐Term Correction of Murine Glycogen Storage Disease Type III by AAV‐Mediated Gene Therapy Using an Immunotolerizing Dual Promoter to Express Bacterial Pullulanase.
- Published in:
- Advances in Cell & Gene Therapy, 2025, v. 2025, p. 1, doi. 10.1155/acg2/4639392
- By:
- Publication type:
- Article